Wst investor alert: robbins geller rudman & dowd llp announces that west pharmaceutical services, inc. investors with substantial losses have opportunity to lead investor class action lawsuit

San diego, may 14, 2025 (globe newswire) -- the law firm of robbins geller rudman & dowd llp announces that purchasers or acquirers of west pharmaceutical services, inc. (nyse: wst) common stock between february 16, 2023 and february 12, 2025, inclusive (the “class period”), have until july 7, 2025 to seek appointment as lead plaintiff of the west pharmaceutical class action lawsuit. captioned new england teamsters pension fund v. west pharmaceutical services, inc., no. 25-cv-02285 (e.d. pa.), the west pharmaceutical class action lawsuit charges west pharmaceutical as well as certain of west pharmaceutical's current and former top executives with violations of the securities exchange act of 1934.
WST Ratings Summary
WST Quant Ranking